Booz Allen Hamilton acquires Epidemico
Epidemico is an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health, including disease outbreaks, drug safety and supply chain vulnerabilities. By combining innovative data acquisition and analysis technologies with public health experience, Epidemico delivers sophisticated surveillance systems and consumer-centric engagement tools.
Epidemico, with a staff of epidemiologists and health leaders, is known for pioneering global population health solutions that radically disrupt traditional detection, reporting and engagement systems. For example, one of Epidemico’s commercially licensed products, HealthMap, provides a digital disease detection service, tracking over 200 infectious diseases worldwide in 15 different languages.
Epidemico’s suite of cloud-based solutions are a trusted resources for the public, government officials, life science, financial and Fortune 500 companies both in the U.S. and internationally. Several products also are directly supported by government entities such as the FDA, Centers for Disease Control and Department of Homeland Security.
Epidemico is a commercial spinoff of Boston Children’s Hospital, Harvard Medical School and the Massachusetts Institute of Technology. The proprietary software platform is transferrable to multiple industries and business-use cases.